Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ZymoGenetics Inc.

Division of Bristol-Myers Squibb Co.
www.zymogenetics.com

Latest From ZymoGenetics Inc.

Bristol Closes, Consolidates R&D Sites Under Cost-Containment Plan

The pharma will consolidate some operations in New Jersey, it won’t renew the lease on a Seattle site acquired with ZymoGenetics deal and intends to close an R&D site in Connecticut as part of a cost-control plan outlined in October.

Research & Development Business Strategies

Former Biogen R&D Chief Surfaces With Exosome-Focused Startup

Douglas Williams turned heads in July when Biogen revealed that its executive vice president leading research and development was leaving to found a biotechnology startup, and now Williams has emerged from the fundraising process as the president and CEO of Codiak BioSciences with venture capital to develop exosomes-based therapeutics and diagnostics.

Cancer Orthopedics

FINANCE ROUNDUP: Three IPOs and three VC rounds

Before they began their summer vacations, three biotechnology companies raised $62m in venture capital financing and three drug developers grossed $232m in initial public offerings.

Metabolic Disorders Gastrointestinal

Novo Nordisk abandons inflammatory disease

Novo Nordisk is dropping all its R&D activities into inflammatory disorders following the discontinuation of its lead anti-inflammatory product, anti-IL-20 for the treatment of rheumatoid arthritis, which it announced last month.

Gastrointestinal Metabolic Disorders
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Bristol-Myers Squibb Co.
  • Senior Management
  • Heather L Franklin, SVP, Bus. Dev.
    Eleanor L Ramos, MD, SVP, CMO
    Dennis M Miller, PhD, SVP, Research & Preclinical Dev.
  • Contact Info
  • ZymoGenetics Inc.
    Phone: (206) 442-6600
    1201 Eastlake Ave. East
    Seattle, WA 98102-3702
    USA
UsernamePublicRestriction

Register